FDA committee votes 9-0 against Cell Therapeutic's pixantrone

Submitted by Ross Bonander Mon 03/22/2010

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

The hopes that Cell Therapeutics has for its drug pixantrone gaining FDA approval took a massive hit today when the FDA's Oncologic Drugs Advisory Committee (ODAC) voted 9-0 against granting the company marketing approval for the medication.

Members of the committee claimed that the single study supporting the drug was neither "well designed nor well executed" and noted that its efficacy-- just 20% of the cohort achieved a major response to the drug -- was below acceptable standards.

The company's shares fell by almost 50% when the news broke. The FDA will make a final decision in late April, but most expect the agency to follow the recommendation of the ODAC.

By Ross Bonander

Source: Reuters

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.